| 1 | Study | 1.37% | |
| 2 | Risk | 0.95% | |
| 3 | Health | 0.89% | |
| 4 | Patients | 0.81% | |
| 5 | Disease | 0.81% | |
| 6 | New | 0.78% | |
| 7 | Cancer | 0.78% | |
| 8 | Treatment | 0.53% | |
| 9 | May | 0.5% | |
| 10 | Chronic | 0.45% | |
| 11 | AI | 0.42% | |
| 12 | According | 0.42% | |
| 13 | Blood | 0.39% | |
| 14 | Clinical | 0.36% | |
| 15 | Therapy | 0.36% | |
| 16 | Diabetes | 0.36% | |
| 17 | Heart | 0.31% | |
| 18 | Cell | 0.31% | |
| 19 | Times | 0.31% | |
| 20 | Researchers | 0.31% | |
| 21 | HIV | 0.31% | |
| 22 | Linked | 0.31% | |
| 23 | Case | 0.31% | |
| 24 | Alzheimer’s | 0.31% | |
| 25 | Weight | 0.28% | |
| 26 | Potential | 0.28% | |
| 27 | Brain | 0.28% | |
| 28 | Hindustan | 0.28% | |
| 29 | Early | 0.28% | |
| 30 | Diet | 0.28% | |
| 31 | Type | 0.25% | |
| 32 | Research | 0.25% | |
| 33 | Gut | 0.25% | |
| 34 | Report | 0.25% | |
| 35 | Obesity | 0.22% | |
| 36 | Key | 0.22% | |
| 37 | Use | 0.22% | |
| 38 | Adults | 0.22% | |
| 39 | Outcomes | 0.22% | |
| 40 | Liver | 0.22% | |
| 41 | Drug | 0.22% | |
| 42 | Review | 0.22% | |
| 43 | Care | 0.22% | |
| 44 | Multiple | 0.22% | |
| 45 | Impact | 0.22% | |
| 46 | Data | 0.22% | |
| 47 | Global | 0.22% | |
| 48 | Finds | 0.22% | |
| 49 | Mortality | 0.22% | |
| 50 | GLP-1 | 0.22% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Phase 2B ExTINGUISH Trial Aims to Assess Efficacy of Inebilizumab for NMDAR Encephalitis
NeurologyLive
2025-06-18 07:06:45
Experts Publish Consensus on CT for Prosthetic Heart Valve Assessment
Radiological Society of North America | RSNA
2025-06-18 01:43:05
Telehealth Geriatric Cancer Assessment Passes Phase III Test in Low-Resource Setting
MedPage Today
2025-06-17 06:38:56
Assessment of the Combined Diagnostic Value of Serum TFF2 and miR-186- | JIR
Dove Medical Press
2025-06-17 01:05:48
Western Sydney University Develops AI Tool to Assess Type 1 Diabetes Risk and Treatment Response
geneonline.com
2025-06-15 06:07:31